Revised EU/Pfizer/BioNTech Covid-19 vaccine deal may lead to a Comirnaty monopoly
The new deal also ensures the EU will have access to the latest versions of future variant-specific updated vaccines once they are authorised for use.
Comment
Negative FDA AdCom vote for Intercept’s obeticholic acid in NASH
Sentiment towards Brexit has worsened three years after UK left EU
US companies drive 2023 drug launches positioned for blockbuster success by 2028
Catalent CEO drops FY2023 revenue forecast by $450m after “disappointing” quarter
After 2022 interest rate hikes spook investors, pharma M&A to resurge in late 2023
Excitement associated with FDA approval of Rinvoq in Crohn’s disease
Supplies of Novo Nordisk’s Wegovy starter doses to be limited
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
